Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty

NCT06611319 is registered in ClinicalTrials.gov with Prof. Stavros Konstantinides, MD as lead sponsor.

NCT NCT06611319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06611319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty
Lead sponsor
Prof. Stavros Konstantinides, MD
Phase
Phase 3
Overall status
Recruiting
Start date
November 26, 2024
Completion date
July 31, 2027
Enrollment
2,932 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hip arthroplasty, total, prevention of venous thromboembolism